nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A molecular view of the function and pharmacology of acid-sensing ion channels
|
Vullo, Sabrina |
|
|
154 |
C |
p. |
artikel |
2 |
Drug-induced endocrine blood pressure elevation
|
Beck, Katharina R. |
|
|
154 |
C |
p. |
artikel |
3 |
Drugs and hepatic transporters: A review
|
Jetter, Alexander |
|
|
154 |
C |
p. |
artikel |
4 |
Editorial Board
|
|
|
|
154 |
C |
p. |
artikel |
5 |
Granulocyte death mediated by specific antibodies in intravenous immunoglobulin (IVIG)
|
Graeter, Stefanie |
|
|
154 |
C |
p. |
artikel |
6 |
Harnessing the immune system to fight cancer with Toll-like receptor and RIG-I-like receptor agonists
|
Bourquin, Carole |
|
|
154 |
C |
p. |
artikel |
7 |
Historical account and current research of pharmacology in Switzerland
|
Rüegg, Urs |
|
|
154 |
C |
p. |
artikel |
8 |
Improvements of symptoms of Alzheimer`s disease by inhibition of the angiotensin system
|
Quitterer, Ursula |
|
|
154 |
C |
p. |
artikel |
9 |
Interprofessional and interdisciplinary collaboration for early phase oncological clinical trials in academia—Myo-inositoltrispyrophophate as model
|
Grossmann, Regina |
|
|
154 |
C |
p. |
artikel |
10 |
Introductory letter by the guest editors
|
Rüegg, Urs |
|
|
154 |
C |
p. |
artikel |
11 |
Letter from the Council of the Swiss Society of Pharmacology and Toxicology (SSPT)
|
Traber, Martin |
|
|
154 |
C |
p. |
artikel |
12 |
Mechanisms of statin-associated skeletal muscle-associated symptoms
|
Bouitbir, Jamal |
|
|
154 |
C |
p. |
artikel |
13 |
Optimisation of vancomycin exposure in neonates based on the best level of evidence
|
Dao, Kim |
|
|
154 |
C |
p. |
artikel |
14 |
Optimization for multidrug combinations: Challenges and perspectives in complex disorders
|
Nowak-Sliwinska, Patrycja |
|
|
154 |
C |
p. |
artikel |
15 |
Pharmacological targeting of age-related changes in skeletal muscle tissue
|
Leuchtmann, Aurel B. |
|
|
154 |
C |
p. |
artikel |
16 |
Pharmacology of nerve growth factor and discovery of tanezumab, an anti-nerve growth factor antibody and pain therapeutic
|
Hefti, Franz |
|
|
154 |
C |
p. |
artikel |
17 |
Potential role of the 3-mercaptopyruvate sulfurtransferase (3-MST)—hydrogen sulfide (H2S) pathway in cancer cells
|
Augsburger, Fiona |
|
|
154 |
C |
p. |
artikel |
18 |
Targeting the S1P receptor signaling pathways as a promising approach for treatment of autoimmune and inflammatory diseases
|
Stepanovska, Bisera |
|
|
154 |
C |
p. |
artikel |
19 |
The long and winding road in pharmaceutical development of canakinumab from rare genetic autoinflammatory syndromes to myocardial infarction and cancer
|
Gram, Hermann |
|
|
154 |
C |
p. |
artikel |